These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17291948)

  • 1. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
    Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
    J Am Coll Cardiol; 2007 Feb; 49(6):734-9. PubMed ID: 17291948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
    Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
    Circulation; 2007 Feb; 115(6):813-8. PubMed ID: 17224480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
    Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):334-40. PubMed ID: 17295287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
    Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
    J Am Dent Assoc; 2007 May; 138(5):652-5. PubMed ID: 17473044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting coronary artery stents.
    Dehmer GJ; Smith KJ
    Am Fam Physician; 2009 Dec; 80(11):1245-51. PubMed ID: 19961137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents.
    Bell B; Layland J; Poon K; Spaulding C; Walters D
    Heart Lung Circ; 2011 Jul; 20(7):438-45. PubMed ID: 21493140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary stent management in elective genitourinary surgery.
    Gupta AD; Streiff M; Resar J; Schoenberg M
    BJU Int; 2012 Aug; 110(4):480-4. PubMed ID: 22192977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents.
    Eberli D; Chassot PG; Sulser T; Samama CM; Mantz J; Delabays A; Spahn DR
    J Urol; 2010 Jun; 183(6):2128-36. PubMed ID: 20399452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
    Lordkipanidzé M; Diodati JG; Pharand C
    Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document.
    Guagliumi G; Musumeci G; Rossini R; Bolognese L; Giordano A; Marzocchi A; Ramondo A; Sangiorgi G; Tamburino C; Tomai F; De Servi S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):782-91. PubMed ID: 17885515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: a case report.
    De Luca G; Carbone G; Maione A; Gregorio G
    Int J Cardiol; 2007 Apr; 116(3):399-400. PubMed ID: 17258334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.